{"ticker": {"uuid": "f4f61f76-f589-4186-b8cf-9ec9cd141ef2", "symbol": "PTP", "name": "Pentixapharm Holding AG       N", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Pentixapharm Holding AG: Resolves on Rights Issue with an Offering Volume of up to Appr. EUR 20.4 Million; Major Shareholder Eckert Wagniskapital Commits to Fully Exercise Its Subscription Rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AJBVV95cUxNeWxnQmVucFFtZ2pBLWp2Wlo2TjN6ei03TWV1M2xrVE84QlhrVXg0NEdMd3BONUFnalZTcHBQZjhPeFE1d2l5cXdUdllfVDlWcFFfWTdySVlSMU55THNweTJBTjI2SE5tNnNsYXdpUDE1WDluLXR3VWR3TGtCclJsV1dlWlVFalZyc1FuQnVyVEl2WHQ3UmdPYWpJTjZ6VGlXczY2dlNPVG44cHdNcmtsbFpWY2txUkVfelZBOENueldFcDNvSWRsMFU4U1lMRzVQTEZnQzhJY2dRc2hUQ2Vtc0V3R2I3MVNMY0hoX2w5VTRoZi1NelpHM0JCektNalBOSDFYNVlTVjdUTnhlUHloOWFxT2VtblBYRVNJSjRsNkJUQXlCOUdmQ2NNLXlYTkNwazM2OVk0ME5TYnRXbUhLMjlxdmRqZmNLdUloYkkzOTI4a2hVUVRVYkNoZUdXNGZHV3NMNQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Pentixapharm Holding (ETR:PTP) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Pentixapharm Holding AG (XETR:PTP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBqQUFubmZQeFBXQTdtcWpOdE03Y19HZVg5aWRsMHlhQ0txRHphQm9zWmFIVGhyU3AxajV2dUttQVVYWURLSUYtaVVPaFNQbjB0R0QzR0R4ZGlvcmZtTkl6NFR5WGZWb28?oc=5", "source_name": "TradingView", "published_at": "2024-10-10T06:18:56+00:00", "published_display": "10 Oct 2024 06:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Pentixapharm Holding AG: Resolves on Rights Issue with an Offering Volume of up to Appr. EUR 20.4 Million; Major Shareholder Eckert Wagniskapital Commits to Fully Exercise Its Subscription Rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AJBVV95cUxNeWxnQmVucFFtZ2pBLWp2Wlo2TjN6ei03TWV1M2xrVE84QlhrVXg0NEdMd3BONUFnalZTcHBQZjhPeFE1d2l5cXdUdllfVDlWcFFfWTdySVlSMU55THNweTJBTjI2SE5tNnNsYXdpUDE1WDluLXR3VWR3TGtCclJsV1dlWlVFalZyc1FuQnVyVEl2WHQ3UmdPYWpJTjZ6VGlXczY2dlNPVG44cHdNcmtsbFpWY2txUkVfelZBOENueldFcDNvSWRsMFU4U1lMRzVQTEZnQzhJY2dRc2hUQ2Vtc0V3R2I3MVNMY0hoX2w5VTRoZi1NelpHM0JCektNalBOSDFYNVlTVjdUTnhlUHloOWFxT2VtblBYRVNJSjRsNkJUQXlCOUdmQ2NNLXlYTkNwazM2OVk0ME5TYnRXbUhLMjlxdmRqZmNLdUloYkkzOTI4a2hVUVRVYkNoZUdXNGZHV3NMNQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Pentixapharm Holding (ETR:PTP) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Pentixapharm Holding AG (XETR:PTP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBqQUFubmZQeFBXQTdtcWpOdE03Y19HZVg5aWRsMHlhQ0txRHphQm9zWmFIVGhyU3AxajV2dUttQVVYWURLSUYtaVVPaFNQbjB0R0QzR0R4ZGlvcmZtTkl6NFR5WGZWb28?oc=5", "source_name": "TradingView", "published_at": "2024-10-10T06:18:56+00:00", "published_display": "10 Oct 2024 06:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 55, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.18, "latest_week": "2026-07-10", "one_week_move": -4.4, "four_week_move": -5.6, "twelve_week_move": 3.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.844122, "market_dynamics_buy_signal": false, "relative_strength": 11.136722, "fair_value_gap": -9.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 40.8472, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.4% over one week, -5.6% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "simplywall.st", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.4% over one week, -5.6% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Pentixapharm Holding AG: Resolves on Rights Issue with an Offering Volume of up to Appr. EUR 20.4 Million; Major Shareholder Eckert Wagniskapital Commits to Fully Exercise Its Subscription Rights"}], "updated_at": "2026-07-17T03:13:04.878414+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}